Windlas Biotech Shares: 'Buy On Dips' Until Breakout, Says SEBI Analyst

2025-09-01 05:00:49

(MENAFN- AsiaNet News)

Windlas Biotech shares have gained nearly 9% in the last three months. SEBI-registered analyst Finkhoz is bullish on the stock, driven by its improving fundamental strength and a bullish chart setup. A clean breakout above ₹1,025 will confirm the next strong uptrend. Until then, it remains a“buy-on-dips” candidate, they added.

Let's take a look at the rationale behind their recommendation.

Fundamental View

Windlas Biotech has demonstrated steady growth over the last two years. Sales have risen from ₹120 crore in June 2022 to ₹210 crore in June 2025, a 75% jump with continuous quarter-on-quarter growth. Its operating profit has also grown from ₹14 crore to ₹27 crore during the same period, while EPS has nearly doubled from ₹4.50 to ₹8.40.

Margins remain stable at 12–13% OPM, and the company continues to operate on a low-debt model, which provides strength during pharma downturns as well.

Technical View

According to Finkhoz, its price action is showing accumulation and strength. The stock has seen strong support near ₹925, its 200-day Exponential Moving Average (EMA). Immediate resistance is pegged at ₹1,025 – a level that has been tested multiple times.

A breakout above ₹1,025 can open the gate to ₹1,160 and higher, according to them. The stock is currently trading above the 50-day EMA (₹967), indicating that the buyers are active on dips.

Windlas Biotech is forming a Cup & Handle pattern on the chart and a breakout above ₹1,025 can open the road towards ₹1,350, they concluded.

News Triggers

The pharma CDMO sector is gaining momentum with PLI scheme tailwinds, and Windlas is a key beneficiary. And according to Finkhoz, Windlas Biotech stands out for its consistent EPS growth and stable margins - making it a steady compounder.

What Is The Retail Mood?

Data on Stocktwits shows that retail sentiment has remained 'neutral.'

Windlas sentiment and message volume on Sep 1 as of 1:30 pm IST. | source: Stocktwits

Windlas shares have declined 3% year-to-date (YTD).

For updates and corrections, email newsroom[at]stocktwits[dot]com.

MENAFN01092025007385015968ID1110000807

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.